Director, Business Development
INVIVOSCRIBE INC
Summary
Invivoscribe is an industry pioneer and global leader in precision oncology diagnostics. We are seeking a strategic, entrepreneurial, and relationship-focused Director, Business Development to expand Invivoscribe's global footprint across the pharmaceutical, biotechnology, and diagnostics sectors. This is a high-impact leadership role for a true dealmaker—someone who excels at the intersection of science, strategy, and commercialization. You will architect and execute partnerships that accelerate adoption of our assays, services, and emerging offerings, helping shape the future of precision oncology.
Job description
Core Responsibilities
Strategic Partnership Development
- Identify, cultivate, and manage high-value partnerships across pharma, biotech, clinical laboratories, and diagnostic technology companies.
- Develop strategic frameworks that align partner needs with Invivoscribe solutions, including CDx co-development, clinical trial support, and global testing programs.
Negotiation & Deal Execution
- Lead the full deal lifecycle, including opportunity evaluation, structuring, negotiation, contracting, and operational transition.
- Drive strategic collaborations, licensing agreements, technology access deals, and companion diagnostic partnerships.
Market & Competitive Insight
- Deliver actionable insights on market trends, competitive dynamics, customer needs, and emerging scientific advancements.
- Inform portfolio strategy, new product opportunities, and geographic market expansion.
Commercial & Scientific Growth Enablement
- Translate complex scientific capabilities into compelling commercial opportunities and business cases.
- Partner cross-functionally with R&D, Product Management, Regulatory, Finance, and Commercial teams to operationalize and scale partnerships.
Core Requirements
- Established network and strong relationships across pharma, biotech, and/or diagnostics to accelerate partnership development.
- Proven success navigating and closing complex deal structures, including CDx, licensing, co-development, and international collaborations.
- Solid understanding of drug development, flow cytometry, molecular diagnostics, clinical research, or advanced biotechnology platforms.
- Bachelor's degree in Life Sciences, Biotechnology, Business, or a related field; 10+ years of business development experience in biotech, pharma, or life sciences with a strong record of closing high-impact partnerships.
- Advanced degree (MBA, MS, PhD, MPH) preferred; equivalent experience considered.
- Resilient and driven. Dealmaker mentality: able to open doors to new opportunities, negotiate, and close high-value, complex deals.
- Adept at influencing stakeholders both direct and indirect, internal and external.
Requirements
- Established network and strong relationships across pharma, biotech, and/or diagnostics
- Proven success navigating and closing complex deal structures, including CDx, licensing, co-development, and international collaborations
- Solid understanding of drug development, flow cytometry, molecular diagnostics, clinical research, or advanced biotechnology platforms
- Bachelor's degree in Life Sciences, Biotechnology, Business, or a related field
- 10+ years of business development experience in biotech, pharma, or life sciences
- Advanced degree (MBA, MS, PhD, MPH) preferred
- Resilient and driven with a dealmaker mentality
- Adept at influencing stakeholders both direct and indirect, internal and external
Benefits
- Competitive compensation
- Performance incentives
- Comprehensive global benefits
- Collaborative culture
- Global impact opportunity
Company overview
Invivoscribe is a global leader in precision diagnostics dedicated to improving lives through innovative molecular diagnostic solutions. Founded in 1995 and headquartered in San Diego, California, the company specializes in developing and manufacturing clinically-validated personalized molecular diagnostic tools for hematologic cancers, particularly leukemias and lymphomas. As pioneers of the world's first approved AML companion diagnostic (CDx), Invivoscribe has established itself as an industry trailblazer with CDx solutions approved for three drugs across key global markets. The company operates through its Laboratory for Personalized Molecular Medicine (LabPMM) network, offering internationally standardized testing services across the United States, Europe, and Asia. Invivoscribe's comprehensive product portfolio includes CE-marked in vitro diagnostic cGMP products, RUO assays, analyte specific reagents, DNA/RNA controls, and proprietary software solutions for next-generation sequencing applications. Their Streamlined CDx model accelerates novel therapeutic development by providing pharmaceutical partners with integrated product development, manufacturing, clinical lab services, and global regulatory expertise.